FOR IMMEDIATE RELEASE

Contact:    Mr. Scott R. Yablon
            MIM Corporation
            Tel. 914-460-1600
            Fax 914-460-1660

                       MIM ADOPTS SHAREHOLDER RIGHTS PLAN

                             - Also amends By-Laws -

ELMSFORD, NY - November 25, 1998 -- MIM Corporation (NASDAQ: MIMS), a pharmacy
benefits management company, announced today that its Board of Directors
unanimously approved the adoption of a Shareholder Rights Plan. Under the Plan,
each holder of Common Stock of MIM will receive a dividend distribution of one
Right for each share of Common Stock held of record as of the close of business
on December 4, 1998. MIM's Board of Directors also unanimously adopted an
amendment to its By-Laws, requiring certain procedural requirements with respect
to stockholder action by written consent.

The Shareholder Rights Plan and By-Law amendments were adopted to deter coercive
takeover tactics and to otherwise encourage third parties interested in
acquiring the Company to negotiate with the Board of Directors, which will
facilitate the Board of Directors' objective to maximize shareholder value.

The Rights are not being distributed and the By-Laws are not being amended in
response to any particular effort to acquire control of the Company and the
Board is not aware of any such effort.


                                       1


Each Right will entitle holders of Common Stock to buy one Unit of Preferred
Stock of MIM at an exercise price of $20.00. Each Unit has substantially the
same economic and voting rights as one share of Common Stock. Until the
Distribution Date (as defined below), the Rights will be evidenced by the Common
Stock certificates and will automatically trade and be transferred along with
the Common Stock. Subject to termination of the Rights Plan by the Board of
Directors, the Rights will be exercisable, and will detach from the Common Stock
(the "Distribution Date") only if a person or group (i) acquires 15% or more of
the outstanding shares of Common Stock of MIM; (ii) announces a tender or
exchange offer that, if consummated, would result in a person or group
beneficially owning 15% or more of the outstanding shares of Common Stock of
MIM; (iii) beneficially owns 10% or more of the outstanding shares of Common
Stock of MIM and is declared by the Board to be an Adverse Person; or (iv)
acquires beneficial ownership of 40% or more of the outstanding shares of Common
Stock of MIM. Upon the occurrence of certain triggering events, each Right will
entitle the holder (other than the acquiring person or group) upon payment of
the exercise price to purchase Units (or, in certain circumstances, common stock
of the acquiring person) with a value equal to twice the exercise price of the
Rights. MIM will be entitled to redeem the Rights at $.0001 per Right at any
time until the Distribution Date. The Rights will expire at the close of
business on November 24, 2008.

Details of the Rights Plan are outlined in a letter to stockholders and a
summary of the Rights Plan that will be mailed to all stockholders promptly
following the December 4, 1998 record date.


                                       2


In addition, the Company amended its By-Laws to institute limitations on, and to
provide notice requirements with respect to, matters to be adopted by written
consent of its stockholders.

MIM Corporation is an independent pharmacy benefit management and mail order
company that partners with managed care organizations and healthcare providers
to control prescription drug costs. MIM provides its customers with innovative
pharmacy benefit products and services utilizing clinically sound guidelines to
ensure cost control and quality care. MIM encourages improved quality of care,
increased patient accessibility and medical cost effectiveness.

The statements in this press release regarding expectations as to future sales
and earnings growth and possible acquisitions, including statements regarding
the intent, belief or current expectations of the Company, its directors, or its
officers with respect to those items, and statements that are preceded by,
followed by or include the words, "believes", "expects", "anticipates" or
similar expressions as well as all other statements herein that are not
historical in nature constitute Forward Looking Statements under the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that such
Forward Looking Statements are not guarantees of future performance and involve
risks and uncertainties that may cause actual results to differ materially from
those Forward Looking Statements. For a discussion of factors that could cause
the actual results to differ from the Company's expectations and the Forward
Looking Statements, please refer to Company's periodic reports and other
documents filed with the Securities and Exchange Commission.


                                       3